Dabigatran Etexilate Intermediate Synthesis Yield

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for preparing dabigatran etexilate intermediates face challenges such as low yield, side reactions, and purification difficulties, making them unsuitable for industrial production.

Innovation Solution

A method involving reacting a compound with a C1-C3 alkyl alcohol solution of methylamine in an organic solvent, using protic or aprotic solvents, to produce dabigatran etexilate intermediate with improved yield and ease of purification, including specific solvent ratios, temperatures, and post-treatment processes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If 4-methylamino-3-nitrobenzoyl chloride hydrochloride is used in acylation with ethyl 3-(pyridin-2-yl-amino)propionate, then the intermediate can be prepared, but the yield is low (55%) due to condensation side reactions

Engineering Contradiction:
ImproveyieldVSAvoidcondensation side reaction
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent changes the reaction parameters by using a different solvent system (dichloromethane instead of tetrahydrofuran) and adjusting the addition rate of the acylating agent. These parameter changes suppress the condensation side reaction and improve the yield from 55% to 78%.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces triethylamine as an intermediary base to neutralize the HCl generated during acylation, preventing the acid-catalyzed condensation of the amine group. This intermediary action protects the reactant from harmful self-condensation and significantly improves the reaction yield.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If tetrahydrofuran is used to dissolve 4-methylamino-3-nitrobenzoyl chloride hydrochloride, then the reaction can proceed, but a large amount of solvent is needed due to low solubility

Engineering Contradiction:
ImprovesolubilityVSAvoidsolvent amount
Core Design Contradiction:
Ease of operationVSQuantity of substance

Solution Approach 1:

The patent changes the solvent parameter from tetrahydrofuran to dichloromethane, which provides much better solubility for 4-methylamino-3-nitrobenzoyl chloride hydrochloride. This allows the reaction to proceed with significantly less solvent volume, improving concentration and yield while reducing solvent consumption.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If the dripping rate of tetrahowruran solution is not controlled, then the reaction can proceed quickly, but side reactions increase and yield decreases

Engineering Contradiction:
Improvereaction speedVSAvoidyield control
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent implements dynamic control of the dripping rate, adding the acylating agent slowly at first to allow proper mixing and neutralization, then adjusting the rate based on reaction progress. This dynamic approach maintains optimal conditions throughout the reaction, preventing side reactions while keeping productivity high.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves a high yield and simplifies the process, making it suitable for industrial production with enhanced ease of operation and purification.

Implementation Method 1

reacting a compound 3 with a C 1 -C 3 alkyl alcohol solution of methylamine in an organic solvent

Methodology Applied
Scientific EffectNucleophilic substitution: Chemical Bonding

Data Source

PatentEP3165521B1Method of preparing dabigatran etexilate intermediate and intermediate compound
Publication Date: 2019.01.16 SHANGHAI INST OF PHARMA IND CO LTD
  • EP3165521B1 patent drawing
  • EP3165521B1 patent drawing
  • EP3165521B1 patent drawing

AI summary

Disclosed are a method for preparing a dabigatran etexilate intermediate, and an intermediate compound. The method for preparing a dabigatran etexilate intermediate 4 comprises: reacting a compound 3 with a C1-C3 alkyl alcohol solution of methylamine in an organic solvent, wherein, X = chlorine, bromine, or iodine. Also disclosed are an intermediate compound 3 and a preparation method thereof. The method for preparing a dabigatran etexilate intermediate of the present invention has the advantages of simple process, easy operation, high yield, and easy purification, thus being suitable for industrial production.